Beninati William, Sanders Mark H.
Pulmonary and Critical Care Medicine, Wilford Hall USAF Medical Center and Uniformed Services University of the Health Sciences, University of Pittsburgh School of Medicine Pulmonary Service, Veterans Affairs Health Care System of Pittsburgh USA, Pittsburgh, USA
Sleep Med Rev. 2001 Feb;5(1):7-23. doi: 10.1053/smrv.2000.0131.
The obstructive sleep apnea/hypopnea syndrome (OSA/H) is characterised by repetitive obstruction of the upper airway during sleep. The consequences of OSA/H include excessive daytime sleepiness, reduced perceived health quality and an increased risk of driving accidents. There is evidence that treatment with nasal continuous positive airway pressure (CPAP) is effective in eliminating these consequences. In addition, OSA/H may also be associated with hypertension and an increased risk of vascular disease, and although there is no clear evidence in this regard, CPAP may be effective alleviating these consequences as well. Nasal CPAP is considered the treatment of choice for clinically significant OSA/H. The optimal CPAP prescription is that which is most effective in eliminating the adverse consequences of OSA/H. Patients should be initially treated with standard CPAP. For those in whom standard CPAP is unsuccessful or intolerable bi-level or self-adjusting modes may be attempted. The nasal CPAP pressure level can be titrated to eliminate apnea, hypopnea, snoring, respiratory arousal and inspiratory flow limitation as a means of predicting successful long-term therapy. The reliability of these physiologic parameters in predicting the optimal long-term CPAP pressure is eroded by the tendency of CPAP pressure-level requirement to decrease with chronic CPAP use, and by other factors that may increase the CPAP pressure requirement. The split-night polysomnogram and unattended auto-CPAP titration have been proposed as efficient means of determining the optimal CPAP pressure, but for patients with subtle OSA/H, underlying cardiopulmonary disease or other forms of sleep-disordered breathing a full-night polysomnogram may be required. The CPAP prescription must include a comfortable well-fitting interface. When CPAP is prescribed it is essential that the patient undergo clinical re-evaluation to ensure that treatment goals are being met.
阻塞性睡眠呼吸暂停低通气综合征(OSA/H)的特征是睡眠期间上呼吸道反复阻塞。OSA/H的后果包括白天过度嗜睡、健康质量感知下降以及交通事故风险增加。有证据表明,经鼻持续气道正压通气(CPAP)治疗可有效消除这些后果。此外,OSA/H还可能与高血压和血管疾病风险增加有关,尽管在这方面尚无明确证据,但CPAP可能也有效缓解这些后果。鼻CPAP被认为是具有临床意义的OSA/H的首选治疗方法。最佳CPAP处方是最有效地消除OSA/H不良后果的处方。患者应首先接受标准CPAP治疗。对于那些标准CPAP治疗失败或无法耐受的患者,可以尝试双水平或自动调节模式。可以调整鼻CPAP压力水平以消除呼吸暂停、低通气、打鼾、呼吸觉醒和吸气气流受限,以此作为预测长期治疗成功的手段。随着慢性CPAP使用,CPAP压力水平需求有降低的趋势,以及其他可能增加CPAP压力需求的因素,削弱了这些生理参数在预测最佳长期CPAP压力方面的可靠性。分段夜间多导睡眠图和无人值守自动CPAP滴定已被提议作为确定最佳CPAP压力的有效方法,但对于轻度OSA/H、潜在心肺疾病或其他形式睡眠呼吸障碍的患者,可能需要进行整夜多导睡眠图检查。CPAP处方必须包括一个舒适且贴合良好的面罩。开具CPAP处方时,患者必须接受临床重新评估,以确保治疗目标得以实现。